6Skochko O V, Kau dasher I P. Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease[J]. Lik Sprava,2012 (5) : 72.
3Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:342
5Rosuvastatin Registration Clinical Trial Group.Cardiovascular Institute and Fu Wai Hospital,Peking Union Medical College and Chinese Academy of Medical Science,Beijing 100037,China.瑞舒伐他汀治疗中国高胆固醇血症患者疗效和安全性的随机双盲多中心对照研究[J].中华心血管病杂志,2007,35(3):207-211. 被引量:117
8Sasaki J,Otonari T,Sawayama Y,et al.Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatineffects on LDL cholesterol,cholesterol absorption and cholesterol synthesis in Japanese patients with hypercholesterolemia(PEAS study)[J].J Atheroscler Thromb,2012,19(5):485-493.
9Jadad AR,Moor RA,Carroll D,et al.Assessing the quality of reports of randomized clinical trials:is blinding necessary[J]?Control Clin Trials,1996,17(1):1-12.
10Bays HE,Davidson MH,Massaad R,et al.Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia(the ACTE Study)[J].Am J Cardiol,2011,108(4):523-530.